Research & Development

The treatment landscape for pancreatic ductal adenocarcinoma has long been characterized by a disheartening series of clinical failures and marginal survival improvements that left patients with few viable options. However, the emergence of daraxonrasib, a specialized oral RAS(ON) multi-selective

The medical world is standing at the precipice of a pharmaceutical revolution that promises to turn the most sophisticated cancer treatments into accessible, off-the-shelf injections. For years, chimeric antigen receptor T-cell therapy has been a beacon of hope for patients with refractory blood

The persistent challenge of oncological treatment lies not only in identifying malignant cells but also in ensuring that the body’s own immune system remains capable of sustaining a prolonged and effective counterattack. Recent advancements published in the journal Nature Nanotechnology represent a

Ivan Kairatov is a distinguished biopharma expert with a profound background in research and development, specializing in metabolic health and technological innovation. With years of experience navigating the complexities of drug development, he offers deep insights into how new treatments

The journey of a child who has successfully navigated the grueling path of cancer treatment does not conclude with the ringing of a ceremonial bell; rather, it marks the commencement of a complex, lifelong endeavor to maintain health within an environment that may inadvertently pose significant

Precision in oncology often hinges on the ability to distinguish microscopic malignant cells from healthy tissue, yet current imaging tools frequently fail during the most critical moments of a procedure. While surgeons increasingly rely on near-infrared fluorescence to navigate complex anatomical